Enforcement Report - Week Of June 01, 2022
Glutathione market share has been predicted to surpass $295 million by 2025.Glutathione industry has been expanding due to the oxidative stress reducing properties of glutathione that have found widespread application in the context of rising stress levels. Glutathione supplements in diet have witnessed demand due to their nutritional benefits and accredited for boosting glutathione industry size.
Enforcement Report - Week of March 11, 2020
There is no medicine for people who suffer concussions. Instead, they are often told to avoid activities such as reading or watching TV, so their brains can rest and recover. Biotech builder ATAI Life Sciences and Neuronasal are looking to change that.
KRS Global Biotechnology Issues Voluntary Nationwide Recall of All Human and Animal Sterile Drug Products
Enforcement Report - Week of August 14, 2019
Enforcement Report - Week of July 17, 2019
Enforcement Report - Week of May 8, 2019
Enforcement Report for Week of February 20, 2019
[2/1/2019] FDA is warning compounders not to use glutathione-L-reduced powder distributed by Letco Medical, Decatur, Alabama, to compound sterile injectable drugs for patients. Based on reported adverse events, the agency has concerns with use of the Letco distributed glutathione to compound injectable drugs due to potential endotoxins.